Michael A. Weber

45.1k total citations · 7 hit papers
499 papers, 21.9k citations indexed

About

Michael A. Weber is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Michael A. Weber has authored 499 papers receiving a total of 21.9k indexed citations (citations by other indexed papers that have themselves been cited), including 377 papers in Cardiology and Cardiovascular Medicine, 163 papers in Endocrinology, Diabetes and Metabolism and 93 papers in Surgery. Recurrent topics in Michael A. Weber's work include Blood Pressure and Hypertension Studies (335 papers), Hormonal Regulation and Hypertension (143 papers) and Heart Rate Variability and Autonomic Control (80 papers). Michael A. Weber is often cited by papers focused on Blood Pressure and Hypertension Studies (335 papers), Hormonal Regulation and Hypertension (143 papers) and Heart Rate Variability and Autonomic Control (80 papers). Michael A. Weber collaborates with scholars based in United States, Germany and United Kingdom. Michael A. Weber's co-authors include George L. Bakris, Stevo Julius, Jan I.M. Drayer, John H. Laragh, Sverre E. Kjeldsen, Stanley S. Franklin, Tsushung A. Hua, Daniel Levy, William B. Kannel and William Gustin and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Michael A. Weber

490 papers receiving 20.5k citations

Hit Papers

Outcomes in hypertensive ... 1997 2026 2006 2016 2004 1997 2008 2006 2011 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
    2004 1.8k citations Stevo Julius, Sverre E. Kjeldsen et al. profile →
  2. Hemodynamic Patterns of Age-Related Changes in Blood Pressure
    1997 1.7k citations Michael A. Weber et al. Circulation profile →
  3. Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients
    2008 1.3k citations Kenneth Jamerson, Michael A. Weber et al. profile →
  4. Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker
    2006 619 citations Stevo Julius, Brent M. Egan et al. profile →
  5. ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly
    2011 406 citations George L. Bakris, Keith C. Ferdinand et al. Circulation profile →
  6. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial
    2022 168 citations Felix Mahfoud, David E. Kandzari et al. profile →
  7. Hypertension management in patients with cardiovascular comorbidities
    2022 91 citations Lucas Lauder, Felix Mahfoud et al. European Heart Journal profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Michael A. Weber 16.8k 6.5k 3.6k 3.2k 1.5k 499 21.9k
Franz H. Messerli 16.2k 1.0× 5.5k 0.8× 3.2k 0.9× 2.4k 0.8× 1.3k 0.9× 415 22.9k
Stevo Julius 22.0k 1.3× 8.3k 1.3× 3.8k 1.1× 2.7k 0.9× 2.1k 1.4× 328 28.2k
Stephen MacMahon 16.4k 1.0× 7.0k 1.1× 4.5k 1.3× 2.7k 0.8× 1.1k 0.8× 265 27.6k
Björn Dahlöf 13.4k 0.8× 6.0k 0.9× 2.8k 0.8× 1.9k 0.6× 1.5k 1.0× 172 16.7k
Joseph L. Izzo 11.4k 0.7× 4.1k 0.6× 2.2k 0.6× 2.0k 0.6× 843 0.6× 186 18.2k
Jackson T. Wright 17.6k 1.0× 5.8k 0.9× 3.4k 0.9× 3.6k 1.1× 1.2k 0.8× 193 27.3k
Guıdo Grassı 23.8k 1.4× 5.3k 0.8× 4.9k 1.4× 3.0k 0.9× 1.2k 0.8× 703 32.3k
Henry R. Black 17.7k 1.0× 7.1k 1.1× 3.6k 1.0× 3.2k 1.0× 1.6k 1.1× 260 30.1k
Robert Fagard 23.9k 1.4× 5.5k 0.8× 4.5k 1.3× 3.6k 1.1× 1.3k 0.9× 489 33.0k
David A. Calhoun 9.3k 0.6× 6.3k 1.0× 3.1k 0.9× 3.1k 1.0× 751 0.5× 246 15.2k

Countries citing papers authored by Michael A. Weber

Since Specialization
Citations

This map shows the geographic impact of Michael A. Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Weber more than expected).

Fields of papers citing papers by Michael A. Weber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Weber. The network helps show where Michael A. Weber may publish in the future.

Co-authorship network of co-authors of Michael A. Weber

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Weber. A scholar is included among the top collaborators of Michael A. Weber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Weber. Michael A. Weber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Søraas, Camilla Lund, Roland E. Schmieder, Kenneth Jamerson, et al.. (2025). Low Achieved Systolic Blood Pressure Related to Kidney Protection in Diabetic and Non-Diabetic High-Risk Hypertensive Patients. American Journal of Hypertension. 38(12). 1106–1119. 1 indexed citations
2.
Mariampillai, Julian E., Roland E. Schmieder, Kenneth Jamerson, et al.. (2025). On-treatment systolic blood pressure and preserved kidney function in hypertensive patients with proteinuria. The VALUE Trial. Blood Pressure. 34(1). 2544715–2544715. 1 indexed citations
3.
Kandzari, David E., Felix Mahfoud, Raymond R. Townsend, et al.. (2025). Long-Term Safety and Efficacy of Renal Denervation: 24-Month Results From the SPYRAL HTN-ON MED Trial. Circulation Cardiovascular Interventions. 18(7). e015194–e015194. 1 indexed citations
4.
Egan, Brent M., Daniel T. Lackland, Susan E. Sutherland, et al.. (2025). PERSPECTIVE – The Growing Global Benefits of Limiting Salt Intake: an urgent call from the World Hypertension League for more effective policy and public health initiatives. Journal of Human Hypertension. 39(4). 241–245.
5.
Schmieder, Roland E., Douglas A. Hettrick, Michael Böhm, et al.. (2024). Novel approaches to define responders to interventional treatment in hypertension: insights from the SPYRAL HTN-OFF and HTN-ON MED trials. Hypertension Research. 48(1). 327–335. 2 indexed citations
6.
Mahfoud, Felix, Raymond R. Townsend, David E. Kandzari, et al.. (2024). SIGNIFICANT NIGHTTIME BLOOD PRESSURE REDUCTIONS AFTER RADIOFREQUENCY RENAL DENERVATION IN PATIENTS WITH UNCONTROLLED HYPERTENSION: POOLED ANALYSIS OF THE SPYRAL HTN TRIALS. Journal of Hypertension. 42(Suppl 1). e137–e138. 1 indexed citations
7.
Vrsalović, Mislav, Camilla Lund Søraas, Maria H. Mehlum, et al.. (2024). Cardiovascular Outcomes in Hypertension-Treated Patients With Peripheral Artery Disease: The VALUE Trial. Hypertension. 81(7). 1628–1636. 2 indexed citations
8.
Kandzari, David E., Michael A. Weber, Atul Pathak, et al.. (2024). Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results From the TARGET BP I Randomized Clinical Trial. Circulation. 149(24). 1875–1884. 26 indexed citations
9.
Mehlum, Maria H., Giuseppe Mancia, Camilla Lund Søraas, et al.. (2023). Middle-Aged and Older Patients With Left Ventricular Hypertrophy: Higher Mortality With Drug Treated Systolic Blood Pressure Below 130 mm Hg. Hypertension. 80(8). 1739–1748. 13 indexed citations
10.
Lauder, Lucas, Felix Mahfoud, Michel Azizi, et al.. (2022). Hypertension management in patients with cardiovascular comorbidities. European Heart Journal. 44(23). 2066–2077. 91 indexed citations breakdown →
11.
Mahfoud, Felix, Horst Sievert, Stefan Bertog, et al.. (2021). Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant Hypertension. Circulation Cardiovascular Interventions. 14(9). e010075–e010075. 9 indexed citations
12.
13.
14.
Holzhauer, Björn, Stevo Julius, Sverre E. Kjeldsen, et al.. (2021). Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus and hypertension. Blood Pressure. 30(2). 82–89. 3 indexed citations
15.
Böhm, Michael, Martin Fahy, Graeme L. Hickey, et al.. (2021). A re-examination of the SPYRAL HTN-OFF MED Pivotal trial with respect to the underlying model assumptions. Contemporary Clinical Trials Communications. 23. 100818–100818. 6 indexed citations
16.
Kandzari, David E., Felix Mahfoud, Deepak L. Bhatt, et al.. (2020). Confounding Factors in Renal Denervation Trials. Hypertension. 76(5). 1410–1417. 23 indexed citations
17.
White, William B., Christopher R. Chapple, Christian Gratzke, et al.. (2018). Cardiovascular Safety of the β3‐Adrenoceptor Agonist Mirabegron and the Antimuscarinic Agent Solifenacin in the SYNERGY Trial. The Journal of Clinical Pharmacology. 58(8). 1084–1091. 17 indexed citations
18.
Ferdinand, Keith C., George L. Bakris, William C. Cushman, et al.. (2018). Comparison of Effectiveness of Azilsartan Medoxomil and Olmesartan in Blacks Versus Whites With Systemic Hypertension. The American Journal of Cardiology. 122(9). 1496–1505. 4 indexed citations
19.
Kjeldsen, Sverre E., Michael A. Weber, Suzanne Oparil, & Kenneth Jamerson. (2008). Combining RAAS and calcium channel blockade: ACCOMPLISH in perspective. Blood Pressure. 17(5-6). 260–269. 3 indexed citations
20.
Weber, Michael A. & Thomas D. Giles. (2006). Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy?. PubMed. 7(2). 45–54. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Franz H. Messerli Breakdown of academic impact, for papers by Stevo Julius Breakdown of academic impact, for papers by Stephen MacMahon Breakdown of academic impact, for papers by Björn Dahlöf Breakdown of academic impact, for papers by Joseph L. Izzo Breakdown of academic impact, for papers by Jackson T. Wright Breakdown of academic impact, for papers by Guıdo Grassı Breakdown of academic impact, for papers by Henry R. Black Breakdown of academic impact, for papers by Robert Fagard Breakdown of academic impact, for papers by David A. Calhoun
Rankless by CCL
2026